Transnational Drug Trafficking Act of 2015
Became Public Law No: 114-154 on 5-16-16.
S.32 was introduced on 1-06-15 by Dianne Feinstein and referred to the Senate Finance and Judiciary Committees and the House Judiciary and Energy and Commerce Committees. Cosponsors were Tom Udall [D-NM], Richard Blumenthal [D-CT], Amy Klobuchar [D-MN], Chuck Grassley [R-IA], Heidi Heitkamp [D-ND], John Cornyn [R-TX], Charles Schumer [D-NY], Kelly Ayotte [R-TX], and Chrisopher Coons [D-DE]. Identical House Bill was H.R. 3380. Related Senate Bill awaiting resolving differences is S.524.
Identical House Bill H.R. 3380 was introduced on 7-29-15 by Tom Marino [R-PA-10] and referred to the Committees Judiciary and Energy and Commerce. Co-sponsored by Pedro Pierluisi [D-PR-At Large]
To provide the Department of Justice with additional tools to target extraterritorial drug trafficking activity, and for other purposes.
SEC. 2. Possession, manufacture or distribution for purposes of unlawful importations.
Amends Section 1009 of the Controlled Substances Import and Export Act (21 U.S.C. 959) in subsection (a) to: “It shall be unlawful for any person to manufacture or distribute a controlled substance in schedule I or II or flunitrazepam or a listed chemical intending, knowing, or having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within a distance of 12 miles of the coast of the United States.
SEC. 3. Trafficking in counterfeit goods or services.
Chapter 113 of title 18, United States Code, is amended in section 2320 “(4) traffics in a drug and knowingly uses a counterfeit mark on or in connection with such drug,” and in subsection (b)(3), in the matter preceding subparagraph (A), by striking “counterfeit drug” and inserting “drug that uses a counterfeit mark on or in connection with the drug”.